Publicaciones en las que colabora con Jesús Héctor Busto Sancirián (12)

2024

  1. Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses

    JACS Au, Vol. 4, Núm. 1, pp. 150-163

2023

  1. Methyl-to-Ethyl Replacement Makes the Difference: Structure-Guided Design of a New Cancer Vaccine Based on a Tn An-gen Surrogate

    VI RSEQ Chemical Biology Group Meeting - ChemBio VI

2020

  1. Synthesis, conformational analysis and: In vivo assays of an anti-cancer vaccine that features an unnatural antigen based on an sp2-iminosugar fragment

    Chemical Science, Vol. 11, Núm. 15, pp. 3996-4006

2018

  1. Oxygen by Carbon Replacement at the Glycosidic Linkage Modulates the Sugar Conformation in Tn Antigen Mimics

    ACS Omega, Vol. 3, Núm. 12, pp. 18142-18152

  2. The use of fluoroproline in MUC1 antigen enables efficient detection of antibodies inpatients with cancer

    29th International Carbohydrate Symposium - ICS2018

  3. Water Sculpts the Distinctive Shapes and Dynamics of the Tumor-Associated Carbohydrate Tn Antigens: Implications for Their Molecular Recognition

    Journal of the American Chemical Society, Vol. 140, Núm. 31, pp. 9952-9960

2017

  1. Design of novel glycopeptide-based cancer vaccines

    16 Congress Spanish Biophysical Society

  2. Effect of glycosylation on mucin-like peptides and implications for molecular recognition by antibodies

    19th European Carbohydrate Symposium EUROCARB

  3. The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer

    Journal of the American Chemical Society, Vol. 139, Núm. 50, pp. 18255-18261

  4. Untangling Tn antigen structure and its first hydration shell

    28th Joint Glycobiology Meeting 2017

2016

  1. Mucin Architecture behind the Immune Response: Design and Evaluation of an Antitumor Vaccine Derived from an Unnatural MUC1 Fragment

    Chemical Science, Vol. 7, Núm. 3, pp. 2294

2014

  1. Designing non-natural cancer vaccines by replacing the methyl group of Thr-10 in MUC1 derivatives

    XI Carbohydrate Symposium